Citation Impact
Citing Papers
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Immunomodulatory Function of Interleukin 28B During Primary Infection With Cytomegalovirus
2014 StandoutNobel
Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis
2015
Recognition of herpesviruses by the innate immune system
2011
A Direct and Indirect Comparison Meta-Analysis on the Efficacy of Cytomegalovirus Preventive Strategies in Solid Organ Transplant
2014
Impact of a Preemptive Strategy After 3 Months of Valganciclovir Cytomegalovirus Prophylaxis in Kidney Transplant Recipients
2010
Prosthetic joint infection with Mycobacterium avium complex in a solid organ transplant recipient
2009
Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation
2015
Preemptive Versus Sequential Prophylactic-Preemptive Treatment Regimens for Cytomegalovirus in Renal Transplantation: Comparison of Treatment Failure and Antiviral Resistance
2010
Polymorphisms in Toll-like receptor genes and susceptibility to infections in allogeneic stem cell transplantation
2009
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation
2013
Detection of Cytomegalovirus DNA in Plasma as an Adjunct Diagnostic for Gastrointestinal Tract Disease in Kidney and Liver Transplant Recipients
2013
Dynamics of cell‐mediated immune responses to cytomegalovirus in pediatric transplantation recipients
2011
Efficacy of Extended Valganciclovir Prophylaxis in Preventing Cytomegalovirus Infection in Pediatric Kidney Transplantation
2014
Association Between Individual and Combined SNPs in Genes Related to Innate Immunity and Incidence of CMV Infection in Seropositive Kidney Transplant Recipients
2015
The Immunology of Posttransplant CMV Infection
2016
Cytomegalovirus Serology and Replication Remain Associated With Solid Organ Graft Rejection and Graft Loss in the Era of Prophylactic Treatment
2014
Randomized Trial of Valganciclovir Versus Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation
2014
24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year Experience
2010
Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection
2012
The Role of Secondary Cytomegalovirus Prophylaxis for Kidney and Liver Transplant Recipients
2014
Antibiotics versus biofilm: an emerging battleground in microbial communities
2019 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Importance of antibiotic penetration in the antimicrobial resistance of biofilm formed by non-pigmented rapidly growing mycobacteria against amikacin, ciprofloxacin and clarithromycin
2011
Influence of Mannose-Binding Lectin Gene Polymorphisms on The Invasiveness of Cytomegalovirus Disease After Solid Organ Transplantation
2009
Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy
2014
CMV: Prevention, Diagnosis and Therapy
2013
Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants
2015
Prosthetic joint infection: diagnosis and management
2011
Delayed-Onset Cytomegalovirus Disease Coded During Hospital Readmission After Kidney Transplantation
2014
The risk of cytomegalovirus recurrence after kidney transplantation
2011
Cytomegalovirus Replication Within the Lung Allograft Is Associated With Bronchiolitis Obliterans Syndrome
2011
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Mannose-binding lectin and Ficolin-2 gene polymorphisms predispose to cytomegalovirus (re)infection after orthotopic liver transplantation
2011
Cytomegalovirus in Solid Organ Transplantation
2013
Review of Cytomegalovirus Infection Findings With Mammalian Target of Rapamycin Inhibitor-Based Immunosuppressive Therapy in De Novo Renal Transplant Recipients
2012
Impact of Antiviral Preventive Strategies on the Incidence and Outcomes of Cytomegalovirus Disease in Solid Organ Transplant Recipients
2013
Co-infections in people with COVID-19: a systematic review and meta-analysis
2020 Standout
State-of-the-Art Monitoring of Cytomegalovirus-Specific Cell-Mediated Immunity After Organ Transplant: A Primer for the Clinician
2012
Recurrence of CMV Infection and the Effect of Prolonged Antivirals in Organ Transplant Recipients
2016
Infection in Solid-Organ Transplant Recipients
2007 Standout
A Hybrid Strategy for the Prevention of Cytomegalovirus-Related Complications in Pediatric Liver Transplantation Recipients
2009
Immunity to fungal infections
2011 Standout
Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses
2015
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial
2011
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Role of Secondary Prophylaxis With Valganciclovir in the Prevention of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients
2017
Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir
2009
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Cytomegalovirus Infections in Solid Organ Transplantation: A Review
2013
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Prevalence and risk factors of recurrent cytomegalovirus infection in kidney transplant recipients.
2014
Prosthetic Joint Infection
2014 Standout
Prosthetic joint infection in solid organ transplant recipients: a retrospective case‐control study
2012
Valganciclovir Prophylaxis against Cytomegalovirus Impairs Lymphocyte Proliferation and Activation in Renal Transplant Recipients
2011
Works of A.J. Eid being referenced
Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation
2008
Relationship between Toll-Like Receptor 2 Polymorphism and Cytomegalovirus Disease after Liver Transplantation
2007
Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients
2009
Clinical features and outcomes of cytomegalovirus retinitis after transplantation
2007
Prosthetic Joint Infection Due to Rapidly Growing Mycobacteria: Report of 8 Cases and Review of the Literature
2007
Microwave ablation of a large renal aspergilloma
2014